This study is designed to evaluate the safety and pharmacokinetics of a single dose (range of doses) of interleukin-12 administered to patients with early HIV disease. This cytokine, which has potent in vitro immunomodulatory activity, has never been given to humans before.
Showing the most recent 10 out of 553 publications